Who’s at greater risk for long-COVID? New study sheds light on vulnerable demographics

A study analyzing 134,444 participants from BRFSS and NHIS reveals that 21.5% and 17.1% respectively suffer from long-COVID, with higher risks in middle-aged, female, Hispanic individuals, those with less education, and residents of certain areas.

BeiGene executive reportedly under investigation in China

Eva Yin, the chief commercial officer for Greater China at BeiGene, is reportedly under investigation by local authorities for alleged ties to an insurance fraud

October 29, 2024

Pharmaceutical Technology Excellence Awards 2023: KAI Conversations – Pharmaceutical Technology

Share this article As a tech innovator, KAI has developed a Conversation Intelligence platform that not only helps clients gain deep actionable insights from the nuances

January 5, 2024

Liquid biopsy may be used to identify gene mutations in pediatric arteriovenous malformations

A study presented today at the Society of NeuroInterventional Surgery’s (SNIS) 20th Annual Meeting indicated that it may be possible to use a less invasive

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.